期 |
标题 |
文件 |
编号 4 (2013) |
Clinical characteristics and pathogenetic mechanisms of development of cognitive disfucntion in chronic kidney disease patients |
|
Rogova I., Fomin V., Damulin I., Minakova E., Yu Seklivanova O., Shashkova E., Petleva Y.
|
卷 17, 编号 1 (2025) |
Clinical cases of acute kidney injury under conditions of exposure to short-term abnormal heat waves |
|
Murkamilov I., Aitbaev K., Fomin V., Yusupov F., Yusupova T., Yusupova Z., Duysheeva G., Khakimov S., Solizhonov Z., Ymankulov D.
|
编号 2 (2017) |
Clinical case of atypical hemolithic-remic syndrome in the child |
|
Galieva G., Imayeva L., Akhmetshin R., Latypova A., Latypov I., Savostyanov K., Tsygin A.
|
编号 1 (2018) |
Clinical case of papillorenal syndrome |
|
Morozov S., Piruzieva O., Dlin V.
|
卷 16, 编号 3 (2024) |
Clinical case of severe recurrent campylobacteriosis in a patient - renal transplant recipient |
|
Iskhakov R., Frolova N., Arbolishvili G., Kuzmenko M., Artyukhina L., Andreev S., Kobzar M., Frolov A.
|
卷 16, 编号 3 (2024) |
Clinical case of successful treatment of granulomatosis with polyangiitis |
|
Frolova N., Mutovina Z., Kobzar M., Arbolishvili G., Pavlov D., Shmeleva D., Manerov F., Lysenko M.
|
编号 6 (2011) |
CLINICAL SIGHNIFICANCE OF ADIPONECTINEMIA IN DEVELOPMENT OF TARGET ORGAN-DAMAGE IN METABOLIC SYNDROME, ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE |
|
Saginova E., Severova M., Gallyamov M., Ermakov N., Rodina A., Fomin V., Mukhin N.
|
编号 2 (2012) |
Klinicheskoe znachenie asimptomnoy bakteriurii u bol'nykh s khronicheskoy serdechnoy nedostatochnost'yu |
|
Arutyunov G., Arutyunov A., Pashkevich D., Voevodina N., Balanina N., Korsunskaya M., Grishina A., Arutiunov G., Arutiunov A., Pashkevich D., Voevodina N., Balanina N., Korsunskaya M., Grishina A.
|
编号 4 (2014) |
Mukhin Role of podocin gene mutations in assessment of resistance of proteinuric nephritis to standard immunosupressive therapy |
|
Girina S., Pulin A., Kornienko V., Pinelis V., Tcygin A., Asanov A., Kozlovskaya L., Fomin V., N.A N.
|
编号 4 (2011) |
Clinical sighnificance of determination of interleukin-8 and interleukin-18 in blood serum and urine in patients with nephrotic syndrome |
|
Lyndin A., Dlin V., Malinovskaya V., Ruzhitskaya E., Shapovalova T., Guseva T., Parshina O., Boyadzhan M., Yudin M.
|
编号 3 (2017) |
Clinical relevance of determination of neutrophil gelatinase-associated lipocalin-2 in children with acute kidney injury |
|
Eremeeva A., Dlin V., Korsunsky A., Zaikova N., Bondarenko E., Kondrikova E.
|
编号 2 (2014) |
The clinical value of the determination of matrix metalloproteinases and their inhibitors in children with autosomal dominant polycystic kidney disease |
|
Bashirova Z., Vozdvizhenskaya E., Osmanov I.
|
编号 4 (2014) |
Clinical value of determination of matrix metalloproteinases and their inhibitors in children with alport syndrome |
|
Bashirova Z., Dlin V., Vozdvizhenskaya E., Osmanov I.
|
卷 14, 编号 1 (2022) |
Clinical value of erythrocitary indices in chronic glomerulonephritis |
|
Murkamilov I., Aitbaev K., Fomin V., Yusupova G., Yusupov F.
|
编号 1 (2019) |
Clinical trial of calcium polystyrene sulfonate for the treatment of hyperkalemia in patients on hemodialysis |
|
Shutov Y., Kotlyarova G., Lysenko K., Fedorov D.
|
编号 2 (2011) |
Klirens kreatinina v dolgosrochnom prognozirovanii riska serdechno-sosudistoy smerti u bol'nykh ostrym koronarnym sindromom bez pod\"emov segmenta ST |
|
Vyalkina Y., Shalaev S.
|
编号 6 (2014) |
Cognitive impairment in patients on hemodialysis |
|
Smirnov A., Vasilieva I., Golubev R.
|
编号 1 (2017) |
Compliance as an important predictor of renal transplantation outcomes |
|
Stolyar A.
|
编号 1 (2017) |
Urine conductivity as a screening test to detect an adverse circadian blood pressure profile |
|
Sokolova A., Dragunov D., Arutyunov G.
|
编号 2 (2016) |
Urine Conductivity a New Marker for Adverse Circadian Blood Pressure Profile |
|
Sokolova A., Dragunov D., Arutyunov G., Kobyakov M.
|
卷 13, 编号 1 (2021) |
Covid-19-associated acute kidney injury: consensus report of the 25TH ACUTE DISEASE quality initiative (ADQI) workgroup: translation of recommendations |
|
Gasanov M., Batyushin M., Litvinov A., Terentyev V.
|
编号 3 (2009) |
Urinary angiotensinogen concentration as a novel marker of cardio-renal syndrome |
|
- -.
|
编号 5 (2011) |
URINARY CONCENTRATION OF MATRIX METALLOPROTEINASES -2 AND -9 AND THEIR TISSUE INHIBITORS IN CHILDREN WITH PYELONEPHRITIS |
|
Leont'eva Y., Paunova S., Kucherenko A., Smirnov I., Novikova V., Revenkova L., Temerina E., Gol'tsova N., Anokhina O.
|
编号 1 (2009) |
Urine levels of matrix metalloproteinases and their inhibitors as the marker of activity of chronic glomerulonephritis |
|
Li O., Bobkova I., Kozlovskaya L., Li O., Bobkova I., Kozlovskaya L.
|
编号 1 (2013) |
Predictive medicine and clinical nephrology |
|
Moukhin N.
|
编号 5 (2010) |
Anaemia correction in diabetic nephropathy: target haemoglobin values and cardiovascular complications |
|
Shestakova M., Martynov S.
|
编号 4 (2012) |
Korrektsiya giperfosfatemii pri khronicheskoy pochechnoy nedostatochnosti: rol' sevelamera |
|
Shilov E.
|
卷 14, 编号 1 (2022) |
Gorrection of nutritional status violations by a diet in patiets on maintenance hemodialysis with and without diabetes type 2 |
|
Tishkina S., Mikhailova N., Kartsev A., Tishkina A., Pushkina A., Derinova E.
|
编号 1 (2009) |
Correction of cerebro-renal syndrome in arterial hypertension with ischemic stroke: efficacy of eprosartan and hydrochlorothiazide |
|
Batyushin M., Postnikova E., Terent'ev V., Derevyankina I., Batiushin M., Postnikova E., Terentiev V., Dereviankina I.
|
编号 3 (2013) |
Laparoscopic nephroureterectomy in children |
|
Aynakulov A., Dzhenalayev D., Shpot E.
|
卷 14, 编号 3 (2022) |
Laparoscopic resection of a kidney graft with a tumor, our experience |
|
Trushkin R., Artyukhina L., Kantimerov D., Isaev T., Shcheglov N., Shevtsov O., Klementieva T.
|
卷 14, 编号 3 (2022) |
Laparoscopic resection of a transplanted kidney with a large tumor |
|
Trushkin R., Artyukhina L., Kantimerov D., Isaev T., Shcheglov N., Shevtsov O., Klementieva T.
|
编号 6 (2013) |
Pulmonary hypertension as a sign of heart involvement in chronic kidney disease progression |
|
Solomakhina N., Kutyrina I., Rudenko T., Vaslyeva M.
|
编号 1 (2015) |
Pulmonary hypertension in dialysis patients |
|
Borodulina E., Karpunin S., Shutov A.
|
编号 2 (2017) |
Drug-induced hypertension in the clinic of internal diseases |
|
Nikolayev A.
|
编号 2 (2019) |
Drug-induced hypersensitivity: molecular mechanisms and modern approaches to diagnosis |
|
Aitbaev K., Murkamilov I., Fomin V., Alymkulova A., Talaibekov M., Murkamilova Z.
|
编号 3 (2011) |
Drug-induced kidney disease in HIV-infected patients: clinical variants, approaches to prevention |
|
Mukhin N., Fomin V.
|
编号 1 (2013) |
Therapeutic tactics in persistent and recurrent secondary (renal) hyperparathyroidism |
|
Vetchinnikova O., Zakharova N.
|
编号 2 (2011) |
Treatment of anemia with methoxypolyethyleneglycol - epoetin beta in patients on haemodyalisis |
|
Shutov E., Lashutin S., Kolomiytseva I., Shuvalov E.
|
编号 4 (2011) |
TREATMENT OF URINARY TRACT INFECTION IN CHILDREN (CLINICAL LECTURE) |
|
- -.
|
编号 3 (2011) |
Treatment of anemia in chronic kidney disease: the present, the past and the future |
|
Shilo V., Denisov A.
|
编号 3 (2013) |
Treatment of patients with urinary incontinence and erectile dysfunction after radical prostatectomy |
|
Glybochko P., Alyaev Y., Vinarov A., Chalyy M., Esilevsky Y., Demidko Y., Myannik S., Demidko L., Epifanova M.
|
编号 3 (2009) |
Loop diuretic treatment: time for new options |
|
- -.
|
编号 4 (2014) |
Local recurrence of prostate cancer in patients after radical prostatectomy. Modern methods of diagnosis and treatment (contrast-enhanced endorectal magnetic resonance imaging, hystoscanning, hifu) |
|
Glybochko P., Alyaev Y., Amosov A., Rapoport L., Bezrukov E., Krupinov G., Novichkov N., Ganzha T., Obukhov A., Lerner Y., Lachinov E.
|
编号 4 (2013) |
Magnesium-containing phosphate-binders: new therapeutic opportunities in chronic kidney disease |
|
Mikhailova N.
|
编号 6 (2011) |
Inborn arterio-venous renal fistules: mini-invasive diagnosis and treament |
|
Glybochko P., Alyaev Y., Kondrashin S., Grigor'ev N., Akopyan G., Shpot' E., Aksenov A., Martirosyan G., Sorokin N.
|
卷 16, 编号 4 (2024) |
Hemostasis system markers (coagulation factors) and left ventricle geometry in proteinuric variants of chronic kidney disease |
|
Murkamilov I., Aitbaev K., Fomin V., Yusupov F., Yusupova T., Yusupova Z., Duysheeva G., Khakimov S., Solizhonov Z., Ymankulov D.
|
编号 3 (2013) |
Marcello Malpighi: a founder of renal glomeruli |
|
Svistunov A., VFomin V., Kupriyanov I.
|
卷 12, 编号 3 (2020) |
Routing of patients with newly diagnosed atypical hemolytic uremic syndrome |
|
Vasina N., Kotenko O.
|
编号 1 (2015) |
Massive hematuria following percutaneous biopsy of the graft in a patient with Wegener's granulomatosis |
|
Jankovoj A., Sinjutin A., Stepanov V., Korshuno K.
|
编号 2 (2014) |
Approaches to treatment of patients with uric acid dysmetabolism |
|
Scherbak A., Lebedeva M.
|
编号 4 (2011) |
INTERDISCIPLINARY APPROACH TO MANAGEMENT OF CHILDREN WITH OBSTRUCTIVE NEPHROPATHY IN PREVENTION OF CHRONIC KIDNEY DISEASE |
|
Makovetskaya G., Terekhin S., Danilova Z., Bazranova Y., Barinov I.
|
卷 13, 编号 2 (2021) |
International symposium "Keto-analogues of amino acids to preserve kidney function in chronic kidney disease" |
|
Yesayan A.
|
编号 2 (2009) |
Membranous nephropathy: how to differentiate primary and paraneoplastic variants? |
|
Mukhin N., Kozlovskaya L., Shilov E., Miroshnichenko N.
|
卷 13, 编号 3 (2021) |
Membranose glomerulonephritis in the practice of a therapist |
|
Murkamilov I., Sabirov I., Fomin V., Murkamilova Z., Kudaibergenova I., Yusupov F.
|
卷 12, 编号 1 (2020) |
Membranous glomerulonephritis: a modern view of the problem and treatment options |
|
Murkamilov I., Sabirov I., Fomin V., Murkamilova Z., Aitbaev K.
|
编号 4 (2011) |
Membranoproliferative glomerulonephritis type II. Case, diagnosis and comments |
|
Tsygin A., Kartamysheva N., Shklyaev D., Leonova L., Povilaytite P.
|
编号 3-4 (2016) |
Membranoproliferative glomerulonephritis: a new classification and pathogenesis |
|
Yurova V., Kozlovskaya N.
|
卷 13, 编号 2 (2021) |
Place and role of plasma purification technologies in treatment of severe forms of granulematosis with polyangiitis in ICU |
|
Vetsheva M., Podkorytova O., Loss K., Kotenko O.
|
编号 2 (2014) |
Metabolic disturbances in the intra-and postoperative period in renal transplantation |
|
Vatazin A., Sinyutin A., Zulkarnayev A., Patyukov K., Kantaria R., Krstic M.
|
编号 3-4 (2016) |
Metabolic disorders of the urinary system in children with acute abdominal pain syndrome |
|
Mikheeva N., Zverev Y., Vykhodtseva G., Lobanov Y., Tokarev V.
|
编号 2 (2013) |
Metaphylaxis in patients with gout, complicated by urolithiasis and nephropathy |
|
Avdoshyn V., Andryukhin M., Annenkov A., Pulbere S., Chugayev V.
|
编号 4 (2018) |
Guidelines for hemodialysis/ hemodiafiltration procedure |
|
Pushkina A., Anashkin V., Shilo V., Shutov Y., Ushakova A., Kotenko O.
|
卷 15, 编号 1 (2023) |
Methods of nutrition therapy of patients with chronic kidney disease |
|
Mikhailova N.
|
卷 15, 编号 2 (2023) |
Mechanisms of albumin loss against the background of the use of modern methods of renal replacement therapy |
|
Litvinov A., Gasanov M., Kuznetsova Y., Gergia S., Shevchenko S.
|
卷 11, 编号 4 (2019) |
The mechanisms of chronic kidney disease progression: evolution of views |
|
Plenkina L., Simonova O., Rozinova V.
|
编号 5-6 (2015) |
Mechanisms of platelet-leukocyte aggregates formation in chronic obstructive pyelonephritis |
|
Barinov E., Balykina A., Kravchenko A.
|
编号 2 (2011) |
mycophenolate mofetil IN TREATMENT OF STEROID-RESISTANT NEPHROTIC SYNDROME IN CHILDREN |
|
Prikhodina L., Turpitko O., Dlin V., Ignatova M.
|
编号 4 (2018) |
Microangiopathic antiphospholipid syndrome in obstetric practice - the risk of generalized thrombotic microangiopathy |
|
Kirsanova T., Vinogradova M., Kolyvanova A.
|
卷 12, 编号 4 (2020) |
MicroRNAS and their significance in the population of dialysis patients |
|
Rind A., Yesayan A., Kayukov I., Zaraysky M.
|
卷 14, 编号 1 (2022) |
MIRNAS AND INDICATORS OF MINERAL METABOLISM IN THE POPULATION OF DIALYSIS PATIENTS |
|
Rind A., Essaian A., Zaraiski M.
|
编号 1 (2014) |
Bone mineral density, bone and phosphate-calcium metabolism parameters in patients with oxalate nephropathy in early stages of chronic kidney disease |
|
Voronina N., Agievich T.
|
编号 3-4 (2016) |
Mineral and bone disorders in patients with chronic obstructive pulmonary disease combined with chronic kidney disease |
|
Bolotova E., Yavlyanskaya V., Dudnikova A.
|
卷 15, 编号 4 (2023) |
Myostatin is an important link in the pathogenesis of protein-energy deficiency in patients on program hemodialysis |
|
Yakovenko A., Yesayan A., Lavrishcheva Y., Rumyantsev A.
|
编号 2 (2017) |
Many-faced thrombotic microangiopatia - "necklace of death' of complications of pregnancy and childbirth |
|
Raspopin Y., Kolesnichenko A., Sinyavskaya N., Miller A., Shifman E., Kulikov A.
|
卷 16, 编号 4 (2024) |
Multifactorial kidney damage in a comorbid patient |
|
Yumasheva V., Komarova I., Rachina S., Mayorov V., Melnik D., Mirzakhamidova S.
|
编号 3 (2009) |
Multiple renal arteries as a cause of resistant arterial hypertension |
|
Mukhin N., Moiseev S., Fomin V., Shvetsov M., vrachi A., Razuvaeva M.
|
编号 5-6 (2012) |
Multiple renal arteries - an epiphenomena or potential cau of arterial hypertension? |
|
Fomin V., Kupriyanov I., Razuvaeva M.
|
卷 14, 编号 1 (2022) |
Can adenosine A2A-receptors be a target for litokinetic therapy in nephrolithiasis? |
|
Barinov E., Malinin Y., Grigoryan K.
|
编号 3 (2009) |
Can we manage arterial hypertension without hydrochlorothiazide? |
|
Fomin V., Fomin V.
|
编号 4 (2012) |
Moy uchitel' nefrologii Evgeniy Mikhaylovich Tareev |
|
Ignatova M.
|
卷 16, 编号 4 (2024) |
Morphological structure of late kidney transplant dysfunction |
|
Rapetskaya N., Komissarov K., Dmitrieva M., Liatkoyskaya T., Kalachyk A.
|
卷 12, 编号 2 (2020) |
Morphological structure of the kidney pathology according to the renal puncture biopsy data |
|
Stolyarevich E., Zhilinskaya T., Varyasin V.
|
编号 3 (2013) |
Morphological basis of ultrasound estimation of acute pyelonephritis in children |
|
Bykovskiy V., NKislyakov A., Runenko V.
|
卷 16, 编号 2 (2024) |
Morphological features of polycystic kidney in acute renal artery occlusion |
|
Trushkin R., Medvedev P., Lagoyskaya Y., Fettser D., Klementieva T.
|
编号 4 (2013) |
Morphological characteristics of ureteropelvic segment in children with inborn hydronephrosis |
|
Ainakulov A., Shpot’ E.
|
编号 5-6 (2012) |
Urinary excretion of matrix metalloproteinases and their inhibitors in type 1 diabetic patients with nephropathy |
|
Bondar I., Klimontov V., Romanov V.
|
编号 3 (2017) |
Urinary biomarker of podotsitarian dysfunction: importance for early diagnosis of kidney damage to type 2 diabetes mellitus |
|
Yarkova N., Borovkov N.
|
卷 13, 编号 3 (2021) |
Urolithiasis as an extra-articular manifestation of ankylosing spondilitis (literature review) |
|
Nikitina N., Kharlamov V.
|
卷 14, 编号 2 (2022) |
Renal dysfunction in patients with acute pulmonary embolism: how to improve prognosis and management tactics? |
|
Klimkin P., Mikhailova Z., Ekimovskih A., Fukina N., Dementieva T.
|
编号 4 (2017) |
Impaired renal function in patients with degenerative distrophic diseases of the spine and axial spondyloarthritis receiving non-steroidal anti-inflammatory drugs |
|
Bichurina D., Gaydukova I., Aparkina A., Khondkaryan E., Rebrov A.
|
编号 1 (2013) |
Violations of the nutritivny status and low-protein diet with keto-analogues of essential amino-acids in prevention of protein and energy deficiency in patients with chronic kidney disease |
|
Milovanov Y., Aleksandrova I., Dobrosmyslov I.
|
编号 2 (2012) |
Malnutrition in haemodialysis treatment of acute and chronic kidney disease (practice guidelines) |
|
Milovanov Y., Aleksandrova I., Milovanova L., Dobrosmyslov I., Milovanov Y., Alexandrova I., Milovanova L., Dobrosmislov I.
|
卷 14, 编号 2 (2022) |
Nutritional disorders among elderly and senile patients depending on the state of renal function |
|
Borkhanova E., Maksudova A., Alaskari S., Derbali M., Konyukhov E.
|
编号 1 (2011) |
Disturbances of calcium-phosphate metabolism disturbances in chronic kidney disease stage III - V |
|
Milovanova L., Milovanov Y., Kozlovskaya L.
|
卷 14, 编号 3 (2022) |
Impaired sleep-wakefulness and quality of life in patients with arterial hypertension and chronic kidney disease |
|
Osipov E., Batyushin M., Nalgieva Z.
|
编号 2 (2013) |
Natriuretic peptides: diagnostic and prognostic significance in chronic kidney disease |
|
Rudenko T., Kutyrina I., Vasylieva M.
|
编号 4 (2018) |
Scientific worldview of Academician S.R. Mirotvortseva (1878-1949) (on the 140th |
|
Morgoshiya T.
|
卷 14, 编号 3 (2022) |
The scientific legacy of professor g.a. zakharin (1829-1897) - A GREAT CLINICIAN AND TEACHER. on the 125th anniversary of the scientist's death |
|
Morgoshiya T., Inkin A.
|
卷 14, 编号 3 (2022) |
Non-diabetic glucosuria in patients with primary chronic pyelonephritis |
|
Berdichevsky V., Zhmurov V., Romanova A., Rasulov F., Khilkevich S., Boldyrev A., Gonyaev A., Bichenova A.
|
301 - 400 的 925 信息 |
<< < 1 2 3 4 5 6 7 8 9 10 > >> |